vs
COLLEGIUM PHARMACEUTICAL, INC（COLL）とBRC Group Holdings, Inc.（RILY）の財務データ比較。上の社名をクリックして会社を切り替えられます
COLLEGIUM PHARMACEUTICAL, INCの直近四半期売上が大きい（$205.4M vs $188.3M、BRC Group Holdings, Inc.の約1.1倍）。BRC Group Holdings, Inc.の純利益率が高く（47.9% vs 8.3%、差は39.7%）。COLLEGIUM PHARMACEUTICAL, INCの前年同期比売上増加率が高い（12.9% vs -21.9%）。過去8四半期でCOLLEGIUM PHARMACEUTICAL, INCの売上複合成長率が高い（19.1% vs -15.4%）
コレギウムファーマシューティカルは、乱用抑止機能を持つ革新的な疼痛管理治療薬の開発・販売を専門とする米国の製薬企業です。主に米国市場で慢性疼痛患者向け徐放性鎮痛剤を提供し、一般医療・専門医療現場の医療従事者向けに製品を展開しています。
COLL vs RILY — 直接比較
売上が大きい
COLL
1.1倍大きい
$188.3M
売上成長率が高い
COLL
+34.8%の差
-21.9%
純利益率が高い
RILY
純利益率が39.7%高い
8.3%
2年売上CAGRが高い
COLL
2年複合成長率
-15.4%
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $205.4M | $188.3M |
| 純利益 | $17.0M | $90.3M |
| 粗利率 | 62.5% | 79.5% |
| 営業利益率 | 29.6% | 32.3% |
| 純利益率 | 8.3% | 47.9% |
| 売上前年比 | 12.9% | -21.9% |
| 純利益前年比 | 35.3% | 1710.8% |
| EPS（希薄化後） | $0.48 | $2.78 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上COLLRILY
| Q4 25 | $205.4M | $188.3M | ||
| Q3 25 | $209.4M | $215.3M | ||
| Q2 25 | $188.0M | $188.2M | ||
| Q1 25 | $177.8M | $197.2M | ||
| Q4 24 | $181.9M | $241.0M | ||
| Q3 24 | $159.3M | $225.5M | ||
| Q2 24 | $145.3M | $256.0M | ||
| Q1 24 | $144.9M | $263.4M |
純利益COLLRILY
| Q4 25 | $17.0M | $90.3M | ||
| Q3 25 | $31.5M | $91.1M | ||
| Q2 25 | $12.0M | $139.5M | ||
| Q1 25 | $2.4M | $-10.0M | ||
| Q4 24 | $12.5M | $-5.6M | ||
| Q3 24 | $9.3M | $-284.4M | ||
| Q2 24 | $19.6M | $-433.6M | ||
| Q1 24 | $27.7M | $-49.2M |
粗利率COLLRILY
| Q4 25 | 62.5% | 79.5% | ||
| Q3 25 | 61.7% | 83.7% | ||
| Q2 25 | 57.7% | 81.3% | ||
| Q1 25 | 54.8% | 81.4% | ||
| Q4 24 | 54.0% | 79.8% | ||
| Q3 24 | 60.8% | 82.1% | ||
| Q2 24 | 62.5% | 84.5% | ||
| Q1 24 | 63.1% | 85.3% |
営業利益率COLLRILY
| Q4 25 | 29.6% | 32.3% | ||
| Q3 25 | 29.7% | 30.4% | ||
| Q2 25 | 18.7% | 5.7% | ||
| Q1 25 | 12.2% | -31.2% | ||
| Q4 24 | 20.9% | -69.2% | ||
| Q3 24 | 21.9% | -36.4% | ||
| Q2 24 | 32.7% | -90.8% | ||
| Q1 24 | 34.1% | -6.1% |
純利益率COLLRILY
| Q4 25 | 8.3% | 47.9% | ||
| Q3 25 | 15.0% | 42.3% | ||
| Q2 25 | 6.4% | 74.1% | ||
| Q1 25 | 1.4% | -5.1% | ||
| Q4 24 | 6.9% | -2.3% | ||
| Q3 24 | 5.9% | -126.1% | ||
| Q2 24 | 13.5% | -169.4% | ||
| Q1 24 | 19.1% | -18.7% |
EPS（希薄化後）COLLRILY
| Q4 25 | $0.48 | $2.78 | ||
| Q3 25 | $0.84 | $2.91 | ||
| Q2 25 | $0.34 | $4.50 | ||
| Q1 25 | $0.07 | $-0.39 | ||
| Q4 24 | $0.36 | $-0.01 | ||
| Q3 24 | $0.27 | $-9.39 | ||
| Q2 24 | $0.52 | $-14.35 | ||
| Q1 24 | $0.71 | $-1.71 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $386.7M | $226.6M |
| 総負債低いほど良い | — | $1.4B |
| 株主資本純資産 | $301.7M | $-171.5M |
| 総資産 | $1.7B | $1.7B |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
現金・短期投資COLLRILY
| Q4 25 | $386.7M | $226.6M | ||
| Q3 25 | $285.9M | $184.2M | ||
| Q2 25 | $222.2M | $267.4M | ||
| Q1 25 | $197.8M | $138.3M | ||
| Q4 24 | $162.8M | $146.9M | ||
| Q3 24 | $120.0M | $159.2M | ||
| Q2 24 | $271.6M | $236.9M | ||
| Q1 24 | $318.0M | $190.7M |
総負債COLLRILY
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
株主資本COLLRILY
| Q4 25 | $301.7M | $-171.5M | ||
| Q3 25 | $274.8M | $-260.5M | ||
| Q2 25 | $232.2M | $-351.7M | ||
| Q1 25 | $234.4M | $-496.8M | ||
| Q4 24 | $228.8M | $-488.2M | ||
| Q3 24 | $234.3M | $-497.6M | ||
| Q2 24 | $216.6M | $-218.3M | ||
| Q1 24 | $222.2M | $228.4M |
総資産COLLRILY
| Q4 25 | $1.7B | $1.7B | ||
| Q3 25 | $1.6B | $1.7B | ||
| Q2 25 | $1.6B | $1.5B | ||
| Q1 25 | $1.6B | $1.5B | ||
| Q4 24 | $1.7B | $1.8B | ||
| Q3 24 | $1.6B | $2.2B | ||
| Q2 24 | $1.1B | $3.2B | ||
| Q1 24 | $1.1B | $5.0B |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $123.0M | $26.2M |
| フリーキャッシュフロー営業CF - 設備投資 | $122.4M | — |
| FCFマージンFCF / 売上 | 59.6% | — |
| 設備投資強度設備投資 / 売上 | 0.3% | — |
| キャッシュ転換率営業CF / 純利益 | 7.25× | 0.29× |
| 直近12ヶ月FCF直近4四半期 | $327.6M | — |
8四半期トレンド — 暦四半期で整列
営業キャッシュフローCOLLRILY
| Q4 25 | $123.0M | $26.2M | ||
| Q3 25 | $78.4M | $-60.6M | ||
| Q2 25 | $72.4M | $-25.6M | ||
| Q1 25 | $55.4M | $184.0K | ||
| Q4 24 | $84.6M | $-2.7M | ||
| Q3 24 | $-9.0M | $19.5M | ||
| Q2 24 | $67.4M | $111.5M | ||
| Q1 24 | $61.9M | $135.4M |
フリーキャッシュフローCOLLRILY
| Q4 25 | $122.4M | — | ||
| Q3 25 | $78.3M | — | ||
| Q2 25 | $72.4M | — | ||
| Q1 25 | $54.6M | — | ||
| Q4 24 | $84.1M | — | ||
| Q3 24 | $-9.2M | — | ||
| Q2 24 | $67.1M | — | ||
| Q1 24 | $61.4M | — |
FCFマージンCOLLRILY
| Q4 25 | 59.6% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 38.5% | — | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 46.2% | — | ||
| Q3 24 | -5.8% | — | ||
| Q2 24 | 46.2% | — | ||
| Q1 24 | 42.3% | — |
設備投資強度COLLRILY
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.4% | — |
キャッシュ転換率COLLRILY
| Q4 25 | 7.25× | 0.29× | ||
| Q3 25 | 2.49× | -0.66× | ||
| Q2 25 | 6.05× | -0.18× | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | — | ||
| Q2 24 | 3.44× | — | ||
| Q1 24 | 2.23× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
COLL
セグメントデータなし
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
